3-hydroxyflavone has been researched along with Carcinoma, Non-Small Cell Lung in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, M; Avgenikos, M; Caburet, J; de Meester, JSB; Dheeraj, A; Kaschula, CH; Mishra, D; Sabarwal, A; Singh, RP; Stander, S; van Otterlo, WAL; van Rooyen, JC | 1 |
| Agarwal, R; Punia, R; Raina, K; Singh, RP | 1 |
| Grzanka, A; Grzanka, D; Hałas-Wiśniewska, M; Klimaszewska-Wiśniewska, A | 1 |
| Singh, RP; Tabasum, S | 1 |
| Bishayee, K; Boujedaini, N; Khuda-Bukhsh, AR; Mukherjee, A; Sikdar, S | 1 |
| Hyun, JW; Kang, KA; Piao, MJ | 1 |
| Chae, S; Hyun, JW; Kang, KA; Kwon, TK; Madduma Hewage, SR; Oh, MC; Piao, MJ; Ryu, YS | 1 |
| Chang, JH; Chien, MH; Chow, JM; Chung, CL; Hung, WY; Kao, SJ; Lee, WJ | 1 |
| Afaq, F; Khan, N; Khusro, FH; Mukhtar, H; Mustafa Adhami, V; Suh, Y | 1 |
9 other study(ies) available for 3-hydroxyflavone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A novel 4'-brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non-small-cell lung cancer without any adverse effects in mice.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; ErbB Receptors; Flavonoids; Flavonols; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; STAT3 Transcription Factor | 2022 |
Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells.
Topics: A549 Cells; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Flavones; Flavonoids; Flavonols; Gene Expression Regulation, Neoplastic; Humans | 2017 |
Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
Topics: A549 Cells; Actins; Antineoplastic Agents; Apoptosis; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Flavonoids; Flavonols; Gene Expression Profiling; Humans; Lung Neoplasms; Neoplasm Metastasis; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Vimentin | 2018 |
Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition.
Topics: AC133 Antigen; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Drug Synergism; Epithelial-Mesenchymal Transition; Erlotinib Hydrochloride; Flavonoids; Flavonols; Humans; Hyaluronan Receptors; Lung Neoplasms; Neoplasm Invasiveness; Phenotype; Stem Cells | 2019 |
Flavonol isolated from ethanolic leaf extract of Thuja occidentalis arrests the cell cycle at G2-M and induces ROS-independent apoptosis in A549 cells, targeting nuclear DNA.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Division; Cell Survival; Disease Models, Animal; DNA, Neoplasm; Dose-Response Relationship, Drug; Flavonols; G2 Phase; Humans; Lung Neoplasms; Mice; Plant Extracts; Plant Leaves; Reactive Oxygen Species; Thuja | 2014 |
Fisetin induces apoptosis in human nonsmall lung cancer cells via a mitochondria-mediated pathway.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Cell Survival; Flavonoids; Flavonols; Humans; Intracellular Space; Lung Neoplasms; Mitochondria; Reactive Oxygen Species; Signal Transduction | 2015 |
Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Death; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Flavonoids; Flavonols; Humans; Lung Neoplasms; Mitochondria; Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Signal Transduction | 2016 |
Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonols; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Protein Kinase Inhibitors; Reactive Oxygen Species | 2017 |
Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.
Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinase Kinases; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Eukaryotic Initiation Factor-4E; Flavonoids; Flavonols; Humans; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; mTOR Associated Protein, LST8 Homolog; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rapamycin-Insensitive Companion of mTOR Protein; Regulatory-Associated Protein of mTOR; Ribosomal Protein S6 Kinases, 70-kDa; Stem Cells; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2012 |